Granite Point Capital Management, L.P. - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q1 2017$350,000
-6.9%
3,5000.0%0.10%
-65.0%
Q4 2016$376,000
-77.6%
3,500
-74.1%
0.30%
-54.3%
Q3 2016$1,680,000
-22.9%
13,500
-11.8%
0.66%
+101.2%
Q4 2015$2,180,000
+21.4%
15,300
-23.5%
0.33%
-73.5%
Q3 2015$1,796,000
-46.5%
20,000
-31.4%
1.23%
+26.0%
Q2 2015$3,358,000
-12.1%
29,160
-27.1%
0.98%
-30.2%
Q1 2015$3,820,000
+42.1%
40,0000.0%1.40%
+11.0%
Q4 2014$2,689,000
+42.4%
40,000
+14.3%
1.26%
+34.0%
Q3 2014$1,889,000
+21.4%
35,0000.0%0.94%
-12.2%
Q2 2014$1,556,00035,0001.07%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q1 2017
NameSharesValueWeighting ↓
SPQ Asia Capital Ltd 228,777$24,597,00012.30%
Ariose Capital Management Ltd 238,841$25,680,0008.36%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 8,400$903,0003.21%
RUDMAN ERROL M 37,001$3,978,0002.76%
INDUS CAPITAL PARTNERS, LLC 167,104$17,967,0002.33%
Ativo Capital Management LLC 90,748$9,757,0002.30%
THOMAS WHITE INTERNATIONAL LTD 130,130$13,991,0002.08%
OBERWEIS ASSET MANAGEMENT INC/ 55,855$6,006,0001.80%
Cormorant Asset Management, LP 112,867$12,135,0001.64%
BARING ASSET MANAGEMENT Ltd 143,512$15,430,0001.06%
View complete list of CHINA BIOLOGIC PRODS INC shareholders